{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:38:54Z","timestamp":1782283134964,"version":"3.54.5"},"publisher-location":"New York, NY","reference-count":30,"publisher":"Springer US","isbn-type":[{"value":"9781071611296","type":"print"},{"value":"9781071611302","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1130-2_10","type":"book-chapter","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T11:02:47Z","timestamp":1605265367000},"page":"139-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Production of Multi-Subtype Influenza Virus-Like Particles by Molecular Fusion with BAFF or APRIL for Vaccine Development"],"prefix":"10.1007","author":[{"given":"Ting-Hsuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Yu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Tsrong","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suh-Chin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,14]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1586\/erv.09.8","volume":"8","author":"JR Haynes","year":"2009","unstructured":"Haynes JR (2009) Influenza virus-like particle vaccines. Expert Rev Vaccines 8:435\u2013445","journal-title":"Expert Rev Vaccines"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4161\/hv.18757","volume":"8","author":"C Lopez-Macias","year":"2012","unstructured":"Lopez-Macias C (2012) Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vaccin Immunother 8:411\u2013414","journal-title":"Hum Vaccin Immunother"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","volume":"411","author":"JS Rossman","year":"2011","unstructured":"Rossman JS, Lamb RA (2011) Influenza virus assembly and budding. Virology 411:229\u2013236","journal-title":"Virology"},{"key":"10_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001501","volume":"3","author":"RA Bright","year":"2008","unstructured":"Bright RA, Carter DM, Crevar CJ et al (2008) Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One 3:e1501","journal-title":"PLoS One"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1128\/JVI.02052-06","volume":"81","author":"FS Quan","year":"2007","unstructured":"Quan FS, Huang C, Compans RW et al (2007) Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 81:3514\u20133524","journal-title":"J Virol"},{"key":"10_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006032","volume":"4","author":"TM Ross","year":"2009","unstructured":"Ross TM, Mahmood K, Crevar CJ (2009) A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PLoS One 4:e6032","journal-title":"PLoS One"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"7163","DOI":"10.1016\/j.vaccine.2011.05.077","volume":"29","author":"HJ Wei","year":"2011","unstructured":"Wei HJ, Chang W, Lin SC et al (2011) Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines. Vaccine 29:7163\u20137172","journal-title":"Vaccine"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/infdis\/jis232","volume":"205","author":"BM Giles","year":"2012","unstructured":"Giles BM, Crevar CJ, Carter DM et al (2012) A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection. J Infect Dis 205:1562\u20131570","journal-title":"J Infect Dis"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","volume":"29","author":"BM Giles","year":"2011","unstructured":"Giles BM, Ross TM (2011) A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets. Vaccine 29:3043\u20133054","journal-title":"Vaccine"},{"key":"10_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042363","volume":"7","author":"CY Wu","year":"2012","unstructured":"Wu CY, Yeh YC, Chan JT et al (2012) A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus. PLoS One 7:e42363","journal-title":"PLoS One"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","volume":"8","author":"MA D'Aoust","year":"2010","unstructured":"D'Aoust MA, Couture MM, Charland N et al (2010) The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 8:607\u2013619","journal-title":"Plant Biotechnol J"},{"key":"10_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015559","volume":"5","author":"N Landry","year":"2010","unstructured":"Landry N, Ward BJ, Trepanier S et al (2010) Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One 5:e15559","journal-title":"PLoS One"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/biot.201300116","volume":"8","author":"SC Lin","year":"2013","unstructured":"Lin SC, Liu WC, Lin YF et al (2013) Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses. Biotechnol J 8:1315\u20131322","journal-title":"Biotechnol J"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1128\/CVI.05206-11","volume":"18","author":"MJ Hossain","year":"2011","unstructured":"Hossain MJ, Bourgeois M, Quan FS et al (2011) Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza. Clin Vaccine Immunol 18:2010\u20132017","journal-title":"Clin Vaccine Immunol"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1128\/JVI.00207-09","volume":"83","author":"LA Perrone","year":"2009","unstructured":"Perrone LA, Ahmad A, Veguilla V et al (2009) Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 83:5726\u20135734","journal-title":"J Virol"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1016\/j.vaccine.2012.03.035","volume":"30","author":"LE Richert","year":"2012","unstructured":"Richert LE, Servid AE, Harmsen AL et al (2012) A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose. Vaccine 30:3653\u20133665","journal-title":"Vaccine"},{"key":"10_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013972","volume":"5","author":"BZ Wang","year":"2010","unstructured":"Wang BZ, Xu R, Quan FS et al (2010) Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection. PLoS One 5:e13972","journal-title":"PLoS One"},{"key":"10_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012410","volume":"5","author":"M Pearton","year":"2010","unstructured":"Pearton M, Kang SM, Song JM et al (2010) Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines. PLoS One 5:e12410","journal-title":"PLoS One"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"7760","DOI":"10.1128\/JVI.01849-09","volume":"84","author":"FS Quan","year":"2010","unstructured":"Quan FS, Kim YC, Vunnava A (2010) Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol 84:7760\u20137769","journal-title":"J Virol"},{"key":"10_CR20","volume-title":"Janeway\u2019s immunobiology","author":"K Murphy","year":"2017","unstructured":"Murphy K, Weaver C (2017) Janeway\u2019s immunobiology, 9th edn. Garland Science, New York, London","edition":"9"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","volume":"18","author":"C Bossen","year":"2006","unstructured":"Bossen C, Schneider P (2006) BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol 18:263\u2013275","journal-title":"Semin Immunol"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"16330","DOI":"10.1074\/jbc.M115.661405","volume":"290","author":"S Schuepbach-Mallepell","year":"2015","unstructured":"Schuepbach-Mallepell S, Das D, Willen L et al (2015) Stoichiometry of heteromeric BAFF and APRIL cytokines dictates their receptor binding and signaling properties. J Biol Chem 290:16330\u201316342","journal-title":"J Biol Chem"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1128\/JVI.06259-11","volume":"86","author":"M Melchers","year":"2012","unstructured":"Melchers M, Bontjer I, Tong T et al (2012) Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses. J Virol 86:2488\u20132500","journal-title":"J Virol"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1128\/JVI.02904-14","volume":"89","author":"S Gupta","year":"2015","unstructured":"Gupta S, Clark ES, Termini JM et al (2015) DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers. J Virol 89:4158\u20134169","journal-title":"J Virol"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"e02435","DOI":"10.1128\/JVI.02435-16","volume":"91","author":"SL Haley","year":"2017","unstructured":"Haley SL, Tzvetkov EP, Meuwissen S et al (2017) Targeting vaccine-induced extrafollicular pathway of B cell differentiation improves rabies postexposure prophylaxis. J Virol 91:e02435\u2013e02416","journal-title":"J Virol"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.antiviral.2017.06.004","volume":"144","author":"SL Haley","year":"2017","unstructured":"Haley SL, Tzvetkov EP, Lytle AG et al (2017) APRIL:TACI axis is dispensable for the immune response to rabies vaccination. Antivir Res 144:130\u2013137","journal-title":"Antivir Res"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/CMR.00046-17","volume":"30","author":"J Sakai","year":"2017","unstructured":"Sakai J, Akkoyunlu M (2017) The role of BAFF system molecules in host response to pathogens. Clin Microbiol Rev 30:991\u20131014","journal-title":"Clin Microbiol Rev"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.antiviral.2019.02.004","volume":"164","author":"JY Hong","year":"2019","unstructured":"Hong JY, Chen TH, Chen YJ et al (2019) Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development. Antivir Res 164:12\u201322","journal-title":"Antivir Res"},{"key":"10_CR29","unstructured":"Invitrogen (2015) Bac-to-Bac\u00ae Baculovirus Expression System an efficient site-specific transposition system to generate baculovirus for high-level expression of recombinant proteins. http:\/\/tools.thermofisher.com\/content\/sfs\/manuals\/bactobac_man.pdf. Accessed 13 Aug 2015"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.antiviral.2016.07.021","volume":"133","author":"WC Liu","year":"2016","unstructured":"Liu WC, Liu YY, Chen TH et al (2016) Multi-subtype influenza virus-like particles incorporated with flagellin and granulocyte-macrophage colony-stimulating factor for vaccine design. Antivir Res 133:110\u2013118","journal-title":"Antivir Res"}],"container-title":["Methods in Molecular Biology","The TNF Superfamily"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1130-2_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T11:03:03Z","timestamp":1605265383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-1130-2_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,14]]},"ISBN":["9781071611296","9781071611302"],"references-count":30,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1130-2_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,14]]},"assertion":[{"value":"14 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}